TALIS BIOMEDICAL CORP - COM NEW (TLIS)

CUSIP: 87424L207

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / COM NEW
Total 13F shares
248,849
Share change
-536,374
Total reported value
$460,371
Price per share
$1.85
Number of holders
2
Value change
-$6,052,498
Number of buys
1
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 87424L207?
CUSIP 87424L207 identifies TLIS - TALIS BIOMEDICAL CORP - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TALIS BIOMEDICAL CORP - COM NEW (TLIS) as of Q3 2024

As of 30 Sep 2024, TALIS BIOMEDICAL CORP - COM NEW (TLIS) was held by 2 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 248,849 shares. The largest 2 holders included BML Capital Management, LLC and Steward Partners Investment Advisory, LLC. This page lists 2 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.